PTK2B and cancer: Aberrant activation of the signalling cascade comprising phosphatidyl inositol kinase (PI3K), protein kinase B (PKB/Akt) and the mammalian target of rapamycin complex 1 (mTORC1) is commonly observed in the majority of human cancers (Laplante & Sabatini, 2012).